Syl611, a novel semisynthetic taxane derivative, reverses multidrug resistance by p-glycoprotein inhibition and facilitating inward transmembrane action

Author: Zhang Yi   Li Hongyan   Wang Hongbo   Su Fuqin   Qu Runjiang   Yin Dali   Dai Jungui   Li Yan   Chen Xiaoguang  

Publisher: Springer Publishing Company

ISSN: 0344-5704

Source: Cancer Chemotherapy and Pharmacology, Vol.66, Iss.5, 2010-10, pp. : 851-859

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next